Study of Aripiprazole in Patients With Bipolar I Disorder

Clinical trial NCT00257972 · COMPLETED

Trial details

NCT number: NCT00257972
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2004-10-01
Primary completion: 2007-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.